{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2016, Part 2
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about seven new drugs recently approved for use.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify indications for the seven new drugs.
- List major adverse reactions to the new drugs.
- Discuss nursing considerations for the new drugs.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$27.95
Credits:
- ANCC 3.0 CH / 3.0 APH
- DC - BON 3.0 CH
- KY-BON 3.0 CH
- GA - BON 3.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N0716A
Published: Jul 2016
Expires: 12/31/2026
Sources:
Nursing2020
Required Passing Score: 13/18 (72%)
Specialties:
Primary Care,
Women's Health